Stocks Comparison
LifeStance Health vs GeneDx: revenue, profit, margins and growth compared
LifeStance Health brought in $1.4B of revenue in fiscal 2025, GeneDx $427.5M in fiscal 2025. Revenue changed by +13.9% at LifeStance Health and +40.0% at GeneDx on the year before, so GeneDx grew faster. LifeStance Health kept 0.7% of its revenue as net profit, GeneDx -4.9%. Free cash flow was $110M at LifeStance Health and $14.3M at GeneDx.
Side by side, latest fiscal year
| LFST | WGS | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $1.4B | $427.5M |
| Revenue growth | +13.9% | +40.0% |
| Net income | $9.7M | -$21M |
| Net margin | 0.7% | -4.9% |
| Free cash flow | $110M | $14.3M |
| Free cash flow margin | 7.7% | 3.3% |
| Earnings per share (diluted) | n/a | -$0.73 |
| Cash | $248.6M | $105M |
| Debt | $282.8M | $54.5M |
| Price to earnings | n/a | n/a |
| Market value | $4.5B | $2.6B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #126 of 523 · Health care | #199 of 523 · Health care |
Over the years
Questions about LifeStance Health and GeneDx
Which is bigger by revenue, LifeStance Health or GeneDx?
LifeStance Health is bigger by revenue: $1.4B in fiscal 2025, against $427.5M for GeneDx in fiscal 2025.
Which keeps more of its revenue as profit, LifeStance Health or GeneDx?
LifeStance Health had a net margin of 0.7% in fiscal 2025; GeneDx had -4.9% in fiscal 2025.
Which grew revenue faster, LifeStance Health or GeneDx?
In their latest fiscal years revenue changed by +13.9% at LifeStance Health and +40.0% at GeneDx.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.